FindTrial
Sign In

Efficacy and safety of "Wenpi Yishen" therapy for preventing postoperative urinary tract infection in patients with BPH after TURP

Efficacy and safety of "Wenpi Yishen" therapy for preventing postoperative urinary tract infection in patients with BPH after TURP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001609
Enrollment
Unknown
Registered
2025-08-26
Start date
2024-09-02
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostate Hyperplasia

Interventions

Placebo group:Take placebo before surgery
Control group:No special intervention
Experimental group:The method of "Wenpi Yishen" was applied before operation

Sponsors

Capital Medical University Beijing Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Meet BPH diagnostic and surgical criteria; (2) Voluntary participation in this clinical study

Exclusion criteria

Exclusion criteria: (1) The presence of infection at any site; (2) had been diagnosed with urinary calculi within three months or combined with hydrops; (3) Have been diagnosed with other urinary diseases such as tumors urinary malformations ADPKD etc.

Design outcomes

Primary

MeasureTime frame
Urinary tract infection after surgery;—

Secondary

MeasureTime frame
Intraoperative blood loss;Therapeutic effect;Syndrome score;IPSS score;SAS anxiety score;Operation time;Adverse reaction;clinical signs and symptoms;Prostate volume;Postoperative blood routine;C-D Postoperative complications;—

Countries

China

Contacts

Public ContactYang Boyu

Capital Medical University Beijing Friendship Hospital

ybyurology@163.com13261190917

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026